Logo image of GBT.PA

GUERBET (GBT.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:GBT - FR0000032526 - Common Stock

14.08 EUR
+0.16 (+1.15%)
Last: 12/19/2025, 7:00:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to GBT. GBT was compared to 66 industry peers in the Health Care Equipment & Supplies industry. GBT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. GBT is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

GBT had positive earnings in the past year.
In the past year GBT had a positive cash flow from operations.
GBT had positive earnings in 4 of the past 5 years.
Each year in the past 5 years GBT had a positive operating cash flow.
GBT.PA Yearly Net Income VS EBIT VS OCF VS FCFGBT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

GBT's Return On Assets of 0.76% is on the low side compared to the rest of the industry. GBT is outperformed by 63.64% of its industry peers.
Looking at the Return On Equity, with a value of 2.06%, GBT is doing worse than 63.64% of the companies in the same industry.
GBT has a worse Return On Invested Capital (3.17%) than 65.15% of its industry peers.
The Average Return On Invested Capital over the past 3 years for GBT is significantly below the industry average of 9.66%.
Industry RankSector Rank
ROA 0.76%
ROE 2.06%
ROIC 3.17%
ROA(3y)-0.17%
ROA(5y)0.94%
ROE(3y)-0.15%
ROE(5y)2.51%
ROIC(3y)4.08%
ROIC(5y)3.99%
GBT.PA Yearly ROA, ROE, ROICGBT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

Looking at the Profit Margin, with a value of 0.96%, GBT is doing worse than 63.64% of the companies in the same industry.
GBT's Profit Margin has declined in the last couple of years.
The Operating Margin of GBT (4.23%) is worse than 65.15% of its industry peers.
GBT's Operating Margin has declined in the last couple of years.
GBT's Gross Margin of 78.03% is amongst the best of the industry. GBT outperforms 90.91% of its industry peers.
GBT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 4.23%
PM (TTM) 0.96%
GM 78.03%
OM growth 3Y2.51%
OM growth 5Y-2.16%
PM growth 3Y-24.58%
PM growth 5Y-15.99%
GM growth 3Y1.72%
GM growth 5Y0.58%
GBT.PA Yearly Profit, Operating, Gross MarginsGBT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), GBT is destroying value.
The number of shares outstanding for GBT remains at a similar level compared to 1 year ago.
The number of shares outstanding for GBT has been increased compared to 5 years ago.
The debt/assets ratio for GBT is higher compared to a year ago.
GBT.PA Yearly Shares OutstandingGBT.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
GBT.PA Yearly Total Debt VS Total AssetsGBT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

GBT has an Altman-Z score of 2.06. This is not the best score and indicates that GBT is in the grey zone with still only limited risk for bankruptcy at the moment.
GBT's Altman-Z score of 2.06 is in line compared to the rest of the industry. GBT outperforms 45.45% of its industry peers.
GBT has a debt to FCF ratio of 8.88. This is a slightly negative value and a sign of low solvency as GBT would need 8.88 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 8.88, GBT is in line with its industry, outperforming 42.42% of the companies in the same industry.
A Debt/Equity ratio of 0.93 indicates that GBT is somewhat dependend on debt financing.
The Debt to Equity ratio of GBT (0.93) is worse than 81.82% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 8.88
Altman-Z 2.06
ROIC/WACC0.47
WACC6.77%
GBT.PA Yearly LT Debt VS Equity VS FCFGBT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

GBT has a Current Ratio of 2.32. This indicates that GBT is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.32, GBT is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
A Quick Ratio of 1.03 indicates that GBT should not have too much problems paying its short term obligations.
The Quick ratio of GBT (1.03) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.32
Quick Ratio 1.03
GBT.PA Yearly Current Assets VS Current LiabilitesGBT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

3

3. Growth

3.1 Past

GBT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -76.89%.
Measured over the past years, GBT shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -15.50% on average per year.
Looking at the last year, GBT shows a decrease in Revenue. The Revenue has decreased by -2.01% in the last year.
The Revenue has been growing slightly by 0.59% on average over the past years.
EPS 1Y (TTM)-76.89%
EPS 3Y-21.06%
EPS 5Y-15.5%
EPS Q2Q%-75.86%
Revenue 1Y (TTM)-2.01%
Revenue growth 3Y4.74%
Revenue growth 5Y0.59%
Sales Q2Q%-7.5%

3.2 Future

GBT is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -5.56% yearly.
GBT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.86% yearly.
EPS Next Y-70.82%
EPS Next 2Y-24.64%
EPS Next 3Y-10.6%
EPS Next 5Y-5.56%
Revenue Next Year-3.81%
Revenue Next 2Y-0.32%
Revenue Next 3Y1.12%
Revenue Next 5Y3.86%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
GBT.PA Yearly Revenue VS EstimatesGBT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M
GBT.PA Yearly EPS VS EstimatesGBT.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3

5

4. Valuation

4.1 Price/Earnings Ratio

GBT is valuated rather expensively with a Price/Earnings ratio of 23.08.
Based on the Price/Earnings ratio, GBT is valued a bit cheaper than the industry average as 69.70% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of GBT to the average of the S&P500 Index (26.38), we can say GBT is valued inline with the index average.
A Price/Forward Earnings ratio of 9.64 indicates a reasonable valuation of GBT.
Based on the Price/Forward Earnings ratio, GBT is valued cheaply inside the industry as 89.39% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of GBT to the average of the S&P500 Index (23.83), we can say GBT is valued rather cheaply.
Industry RankSector Rank
PE 23.08
Fwd PE 9.64
GBT.PA Price Earnings VS Forward Price EarningsGBT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, GBT is valued cheaply inside the industry as 93.94% of the companies are valued more expensively.
100.00% of the companies in the same industry are more expensive than GBT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 3.97
EV/EBITDA 3.88
GBT.PA Per share dataGBT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

A cheap valuation may be justified as GBT's earnings are expected to decrease with -10.60% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-24.64%
EPS Next 3Y-10.6%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.69%, GBT has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 1.16, GBT pays a better dividend. On top of this GBT pays more dividend than 84.85% of the companies listed in the same industry.
GBT's Dividend Yield is a higher than the S&P500 average which is at 1.87.
Industry RankSector Rank
Dividend Yield 2.69%

5.2 History

The dividend of GBT decreases each year by -10.05%.
Dividend Growth(5Y)-10.05%
Div Incr Years0
Div Non Decr Years1
GBT.PA Yearly Dividends per shareGBT.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 0.2 0.4 0.6 0.8

5.3 Sustainability

81.48% of the earnings are spent on dividend by GBT. This is not a sustainable payout ratio.
GBT's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP81.48%
EPS Next 2Y-24.64%
EPS Next 3Y-10.6%
GBT.PA Yearly Income VS Free CF VS DividendGBT.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M
GBT.PA Dividend Payout.GBT.PA Dividend Payout, showing the Payout Ratio.GBT.PA Dividend Payout.PayoutRetained Earnings

GUERBET

EPA:GBT (12/19/2025, 7:00:00 PM)

14.08

+0.16 (+1.15%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-23 2025-10-23
Earnings (Next)02-05 2026-02-05
Inst Owners10.76%
Inst Owner ChangeN/A
Ins Owners5.01%
Ins Owner ChangeN/A
Market Cap177.97M
Revenue(TTM)809.67M
Net Income(TTM)7.74M
Analysts46
Price Target15.56 (10.51%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.69%
Yearly Dividend0.5
Dividend Growth(5Y)-10.05%
DP81.48%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-6.15%
PT rev (3m)-41.9%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-60.62%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-6.14%
Valuation
Industry RankSector Rank
PE 23.08
Fwd PE 9.64
P/S 0.22
P/FCF 3.97
P/OCF 1.9
P/B 0.47
P/tB 0.65
EV/EBITDA 3.88
EPS(TTM)0.61
EY4.33%
EPS(NY)1.46
Fwd EY10.38%
FCF(TTM)3.55
FCFY25.22%
OCF(TTM)7.41
OCFY52.59%
SpS64.06
BVpS29.76
TBVpS21.75
PEG (NY)N/A
PEG (5Y)N/A
Graham Number20.21
Profitability
Industry RankSector Rank
ROA 0.76%
ROE 2.06%
ROCE 4.49%
ROIC 3.17%
ROICexc 3.67%
ROICexgc 4.33%
OM 4.23%
PM (TTM) 0.96%
GM 78.03%
FCFM 5.54%
ROA(3y)-0.17%
ROA(5y)0.94%
ROE(3y)-0.15%
ROE(5y)2.51%
ROIC(3y)4.08%
ROIC(5y)3.99%
ROICexc(3y)4.61%
ROICexc(5y)4.69%
ROICexgc(3y)5.43%
ROICexgc(5y)6.06%
ROCE(3y)5.76%
ROCE(5y)5.64%
ROICexgc growth 3Y-4.82%
ROICexgc growth 5Y-5.63%
ROICexc growth 3Y2.13%
ROICexc growth 5Y-2.41%
OM growth 3Y2.51%
OM growth 5Y-2.16%
PM growth 3Y-24.58%
PM growth 5Y-15.99%
GM growth 3Y1.72%
GM growth 5Y0.58%
F-Score5
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 8.88
Debt/EBITDA 3.26
Cap/Depr 66.32%
Cap/Sales 6.02%
Interest Coverage 1.61
Cash Conversion 86.9%
Profit Quality 580.05%
Current Ratio 2.32
Quick Ratio 1.03
Altman-Z 2.06
F-Score5
WACC6.77%
ROIC/WACC0.47
Cap/Depr(3y)72.12%
Cap/Depr(5y)80.72%
Cap/Sales(3y)6.9%
Cap/Sales(5y)7.15%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-76.89%
EPS 3Y-21.06%
EPS 5Y-15.5%
EPS Q2Q%-75.86%
EPS Next Y-70.82%
EPS Next 2Y-24.64%
EPS Next 3Y-10.6%
EPS Next 5Y-5.56%
Revenue 1Y (TTM)-2.01%
Revenue growth 3Y4.74%
Revenue growth 5Y0.59%
Sales Q2Q%-7.5%
Revenue Next Year-3.81%
Revenue Next 2Y-0.32%
Revenue Next 3Y1.12%
Revenue Next 5Y3.86%
EBIT growth 1Y-41.57%
EBIT growth 3Y7.37%
EBIT growth 5Y-1.59%
EBIT Next Year50.63%
EBIT Next 3Y21.02%
EBIT Next 5Y21.78%
FCF growth 1Y183.49%
FCF growth 3Y-28.77%
FCF growth 5Y-19.52%
OCF growth 1Y2774.75%
OCF growth 3Y-11.2%
OCF growth 5Y-9.16%

GUERBET / GBT.PA FAQ

What is the ChartMill fundamental rating of GUERBET (GBT.PA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to GBT.PA.


Can you provide the valuation status for GUERBET?

ChartMill assigns a valuation rating of 5 / 10 to GUERBET (GBT.PA). This can be considered as Fairly Valued.


How profitable is GUERBET (GBT.PA) stock?

GUERBET (GBT.PA) has a profitability rating of 3 / 10.


Can you provide the financial health for GBT stock?

The financial health rating of GUERBET (GBT.PA) is 4 / 10.


How sustainable is the dividend of GUERBET (GBT.PA) stock?

The dividend rating of GUERBET (GBT.PA) is 4 / 10 and the dividend payout ratio is 81.48%.